AllTest Biotech Overview
- Year Founded
-
2009
- Status
-
Public
- Employees
-
992
- Stock Symbol
-
688606
- Share Price
-
$6.65
- (As of Friday Closing)
AllTest Biotech General Information
Description
Hangzhou Alltest Biotech Co Ltd is engaged in the research and development, production and sales of in vitro diagnostic reagents.
Contact Information
Website
www.alltests.com.cnCorporate Office
- 550 Yinhai street
- Hangzhou Economic and Technologic Development Area
- Hangzhou, Zhejiang 310018
- China
Corporate Office
- 550 Yinhai street
- Hangzhou Economic and Technologic Development Area
- Hangzhou, Zhejiang 310018
- China
AllTest Biotech Stock Performance
As of 13-Nov-2026, AllTest Biotech’s stock price is $6.65. Its current market cap is $503M with 75.7M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $6.65 | $6.78 | $5.85 - $10.45 | $503M | 75.7M | 349K | $0.21 |
AllTest Biotech Financials Summary
As of 30-Sep-2026, AllTest Biotech has a trailing 12-month revenue of $128M.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 246,115 | 373,668 | 324,405 | 383,292 |
| Revenue | 128,468 | 125,894 | 120,770 | 106,673 |
| EBITDA | 13,835 | 37,282 | 48,358 | 27,273 |
| Net Income | 16,443 | 30,619 | 42,154 | 25,524 |
| Total Assets | 598,053 | 606,347 | 573,420 | 580,659 |
| Total Debt | 1,003 | 1,059 | 561 | 3,374 |
AllTest Biotech Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
AllTest Biotech Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|
AllTest Biotech Patents
AllTest Biotech Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-D1149098-S1 | Test strip | Active | 19-Sep-2025 | ||
| JP-3253642-U | Liquid sample dissolution detection device | Active | 18-Sep-2025 | ||
| US-D1140084-S1 | Pregnancy test | Active | 11-Aug-2025 | ||
| US-D1144963-S1 | Blood testing apparatus | Active | 25-Jul-2025 | ||
| US-D1140083-S1 | Sampling and testing device | Active | 09-Jun-2025 |
AllTest Biotech Signals
AllTest Biotech ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Healthcare
Industry
Rank
Percentile
Medical Devices
Subindustry
Rank
Percentile
AllTest Biotech FAQs
-
When was AllTest Biotech founded?
AllTest Biotech was founded in 2009.
-
Where is AllTest Biotech headquartered?
AllTest Biotech is headquartered in Hangzhou, China.
-
What is the size of AllTest Biotech?
AllTest Biotech has 992 total employees.
-
What industry is AllTest Biotech in?
AllTest Biotech’s primary industry is Diagnostic Equipment.
-
Is AllTest Biotech a private or public company?
AllTest Biotech is a Public company.
-
What is AllTest Biotech’s stock symbol?
The ticker symbol for AllTest Biotech is 688606.
-
What is the current stock price of AllTest Biotech?
As of 13-Nov-2026 the stock price of AllTest Biotech is $6.65.
-
What is the current market cap of AllTest Biotech?
The current market capitalization of AllTest Biotech is $503M.
-
What is AllTest Biotech’s current revenue?
The trailing twelve month revenue for AllTest Biotech is $128M.
-
What is AllTest Biotech’s annual earnings per share (EPS)?
AllTest Biotech’s EPS for 12 months was $0.21.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process